1-R01 GM60548/GM/NIGMS NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
2005	7
2006	5
2007	1
2021	0

1

A common novel CYP2C19 gene variant causes ultrarapid drug metabolism relevant for the drug response to proton pump inhibitors and antidepressants.

Sim SC, Risinger C, Dahl ML, Aklillu E, Christensen M, Bertilsson L, Ingelman-Sundberg M. Sim SC, et al. Clin Pharmacol Ther. 2006 Jan;79(1):103-13. doi: 10.1016/j.clpt.2005.10.002. Clin Pharmacol Ther. 2006. PMID: 16413245

2

Novel extrahepatic cytochrome P450s.

Karlgren M, Miura S, Ingelman-Sundberg M. Karlgren M, et al. Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):57-61. doi: 10.1016/j.taap.2004.12.022. Toxicol Appl Pharmacol. 2005. PMID: 15987645 Review.

3

Cytochrome P450 pharmacogenetics and cancer.

Rodriguez-Antona C, Ingelman-Sundberg M. Rodriguez-Antona C, et al. Oncogene. 2006 Mar 13;25(11):1679-91. doi: 10.1038/sj.onc.1209377. Oncogene. 2006. PMID: 16550168 Review.

4

The human genome project and novel aspects of cytochrome P450 research.

Ingelman-Sundberg M. Ingelman-Sundberg M. Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):52-6. doi: 10.1016/j.taap.2005.01.030. Toxicol Appl Pharmacol. 2005. PMID: 15993453 Review.

5

Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers.

Rodríguez-Antona C, Jande M, Rane A, Ingelman-Sundberg M. Rodríguez-Antona C, et al. Clin Pharmacol Ther. 2005 Apr;77(4):259-70. doi: 10.1016/j.clpt.2004.11.003. Clin Pharmacol Ther. 2005. PMID: 15903124

6

Characterization of the novel defective CYP2C9*24 allele.

Herman D, Dolzan V, Ingelman-Sundberg M. Herman D, et al. Drug Metab Dispos. 2007 Jun;35(6):831-4. doi: 10.1124/dmd.106.013722. Epub 2007 Mar 1. Drug Metab Dispos. 2007. PMID: 17332144

7

A novel polymorphic cytochrome P450 formed by splicing of CYP3A7 and the pseudogene CYP3AP1.

Rodriguez-Antona C, Axelson M, Otter C, Rane A, Ingelman-Sundberg M. Rodriguez-Antona C, et al. J Biol Chem. 2005 Aug 5;280(31):28324-31. doi: 10.1074/jbc.M502309200. Epub 2005 Jun 2. J Biol Chem. 2005. PMID: 15937338 Free article.

8

Identification and characterization of CYP3A4*20, a novel rare CYP3A4 allele without functional activity.

Westlind-Johnsson A, Hermann R, Huennemeyer A, Hauns B, Lahu G, Nassr N, Zech K, Ingelman-Sundberg M, von Richter O. Westlind-Johnsson A, et al. Clin Pharmacol Ther. 2006 Apr;79(4):339-49. doi: 10.1016/j.clpt.2005.11.015. Epub 2006 Feb 28. Clin Pharmacol Ther. 2006. PMID: 16580902

9

Identification of a novel specific CYP2B6 allele in Africans causing impaired metabolism of the HIV drug efavirenz.

Wang J, Sönnerborg A, Rane A, Josephson F, Lundgren S, Ståhle L, Ingelman-Sundberg M. Wang J, et al. Pharmacogenet Genomics. 2006 Mar;16(3):191-8. doi: 10.1097/01.fpc.0000189797.03845.90. Pharmacogenet Genomics. 2006. PMID: 16495778

10

Phenotype-genotype variability in the human CYP3A locus as assessed by the probe drug quinine and analyses of variant CYP3A4 alleles.

Rodríguez-Antona C, Sayi JG, Gustafsson LL, Bertilsson L, Ingelman-Sundberg M. Rodríguez-Antona C, et al. Biochem Biophys Res Commun. 2005 Dec 9;338(1):299-305. doi: 10.1016/j.bbrc.2005.09.020. Epub 2005 Sep 13. Biochem Biophys Res Commun. 2005. PMID: 16171783

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results